New class of weight-loss drugs could reduce mortality: Swiss Re
GLP-1 drugs may reduce mortality by up to 6.4% in the US by 2045 Swiss Re’s optimistic scenario estimates GLP-1 drugs could lead to a reduction in cumulative all-cause mortality in the US general...